Helios Klinikum Erfurt
Maximum-care hospital in Erfurt, Germany, owned by Helios Kliniken GmbH (Fresenius group), whose hospital pharmacy uses an extrusion-based 3D printer to produce personalized oral medicines in clinical studies planned for over 1,000 patients across four German hospitals.
- CEO / Founder
- Christopher Arndt
- Team Size
- 1001-5000
- Stage
- Active
- Key Investors
- Helios Kliniken GmbH (owner, Fresenius group)
Technology & Products
Key Products
Hospital-pharmacy production of 3D-printed soft, flavored, dose-adjustable oral formulations using syringes filled with active ingredient in place of printer cartridges; two clinical studies in geriatrics and pediatrics.
Technical position · AMPulse analysis
One of few German hospital pharmacies running a pharmaceutical 3D printer, after about two years of preparation and regulator approval work.
Differentiation
Value Proposition
Point-of-care production of patient-specific medicines in the hospital pharmacy, with adjustable dose, shape, consistency and taste.
How They Differentiate
Largest hospital in the region (about 1,282 beds) and leads a multi-site clinical study of printed medicines.
Market & Competition
Target Customers
Pediatric and geriatric patients who cannot swallow conventional tablets; hospital clinicians and pharmacists.
Industry Verticals
Healthcare; Pharmaceuticals
Competitors
Universitätsmedizin Mainz (hospital pharmacy 3D printing); Mühlenkreiskliniken (hospital pharmacy 3D printing)
Growth & Milestones
Growth Metrics
About 1,282 beds and roughly 2,000 employees (Wikipedia); more than 1,000 patients planned in the 3D-printed medicine studies.
Major Milestones
1994: Klinikum Erfurt GmbH emerged from the former Medizinische Akademie Erfurt; 1997/2002: Helios acquired the shares; 2023: hospital pharmacy began producing medicines with a 3D printer (alpha phase); April 2026: two studies with over 1,000 patients across four hospitals reported.